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Objectives: to compare general, epidural and local anaesthesia for endovascular aneurysm repair (EVAR).
Methods: retrospective analysis of 91 consecutive patients (age 43 to 89 years) who underwent EVAR under local (LA,
63 patients), epidural (EDA, 8 patients) and general (GA, 20 patients) anaesthesia.
Results: EVAR was successfully achieved in all patients without mortality or neurological, cardiac and respiratory
complications. Vasopressive support as well as median fluid balance were significantly lessened in the LA group compared
to GA group (p<0.0002). Stay in the Intensive Care Unit was necessary in 17 (27%), four (50%) and 14 (70%) patients,
respectively, and median hospital stay was 3, 4.5, and 5.5 days, with a statistically significant difference between LA and
GA group (p<0.0005).
Conclusion: LA is a safe anaesthetic method for the endovascular repair of infrarenal abdominal aneurysm, offering
several advantages: simplicity, stable haemodynamics, and reduced consumption of ICU and hospital beds.
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Introduction undergone EVAR. All patients gave informed consent
for this new type of surgery, which was approved by
Endovascular aneurysm repair1–9 may offer a number the local ethics committee. Preoperative, intra-
operative, and postoperative patient data were pro-of significant advantages over conventional repair for
a proportion of patients with infra-renal abdominal spectively recorded (Table 1). Thirteen patients were
operated on an emergency basis, because of a symp-aortic aneurysm (AAA). The development of new
anaesthetic techniques for EVAR has, however, lagged tomatic aneurysm (eight patients) or a retroperitoneal
rupture (five patients).behind.6,10,11 A few authors12,13 have anecdotally re-
ported the feasibility of local anaesthesia (LA). This
method of anaesthesia has rapidly become our pre-
ferred approach for EVAR. The aim of this paper is to
compare the results of local (LA), epidural (EDA) and
Anaesthetic techniquesgeneral anaesthesia (GA) for EVAR in a retrospective,
non-randomised study.
Preoperative medication was continued until the
morning of surgery and elective patients had a mini-
mum fasting period of 6 h. As premedication, oral
Materials and Methods flunitrazepam was administered. All patients received
pre-operative cephazolin intravenously.
Patients data A radial arterial line, a two- or three-lumen central
venous catheter, a 14G peripheral venous catheter
Since June 1997, 91 patients (87 men, four women, and a urinary Foley catheter were placed. Continuous
average age 71±8 years, range 43–89 years) have electrocardiogram (ECG) (leads II and V5), invasive
arterial pressure, central venous pressure (CVP), trans-
cutaneous oxygen saturation (O2Sat) and urine output∗ Please address all correspondence to: D. A. Bettex, Cardiac An-
aesthesia, USZ-Ra¨mistrasse 100, CH-8091 Zu¨rich. were monitored. Fifty percent oxygen in air was given
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Table 1. Patients’ data.
LA (63) EDA (8) GA (20) Total (91)
Age (years) 71 (43–89) 71 (62–84) 70 (51–89) 71 (43–89)
Weight (kg) 77.5 (50–108) 73.4 (63.3–113) 73 (63–100) 76.5 (50–113)
Sex (M/F) 61/3 8/0 23/1 87/4
ASA III 28 (44%) 3 (38%) 9 (45%) 40 (44%)
ASA IV 35 (56%) 5 (63%) 11 (55%) 51 (56%)
Hypertension 40 (64%) 5 (63%) 10 (50%) 55 (60%)
CAD 40 (64%) 3 (38%) 11 (55%) 54 (59%)
previous CABG 18 1 5 24
Ejection fraction Ζ40% 9 (10%) 2 (25%) 1 (4%) 12 (13%)
Pneumopathy 23 (37%) 5 (63%) 6 (30%) 34 (37%)
Ethylism 4 (6%) 1 (13%) 1 (4%) 6 (6%)
Liver cirrhosis 1 1 0 2 (2%)
Creatinine >120 M/l 20 (32%) 0 3 (15%) 23 (25%)
Chronic dialysis 2 0 0 2
Cerebro-vasc. event 10 0 1 11 (12%)
Diabetes mellitus II 7 1 2 10 (11%)
Neoplasie 2 0 2 4 (4%)
Values are expressed as number of patients (%) or median (range). The conversions from EDA or LA to GA are included in the GA group.
CAD: coronary artery disease defined as a previous anamnestic or electrocardiographic myocardial infarction, a positive ergometry or
coronary angiography; CABG: coronary artery bypass graft. ASA: American Society of Anesthesiologists risk stratification.25 No significant
differences between groups.
by mask to patients under LA or EDA. Patients laid in six patients. There were four surgical complications
(three patients suffered from local bleeding (amongon a warming mattress.
Anaesthesia was dependent on the site of surgical which one required a retroperitoneal surgical ap-
proach), and one patient required a cross-over surgery)incision (femoral or iliac access) and to a lesser extent
on the anaesthesiologist’s preference. Usual contra- and two anaesthetic complications (one refractory
upper airway closure after a bolus of sufentanil andindications to epidural anaesthesia (EDA) were ob-
served. Adequate sedation was supplemented to one failure to obtain satisfactory epidural anaesthesia).
Among the five patients with ruptured aneurysm,patients receiving LA or EDA (see below). Local an-
aesthesia was achieved with bilateral inguinal in- four had a LA and one had a GA; six patients with
symptomatic aneurysm without rupture underwentfiltration of lidocaine 0.5–1% to a maximum of 500 mg.
The epidural catheter was placed between L3 and L5. LA and two GA.
A sensory anaesthetic level at T10 was established
with bupivacaine 0.5%. Intravenous sedation involved
a titration of midazolam and/or a continuous infusion
Surgical technique and early outcomeof low-dose propofol, supplemented as required with
fentanyl, sufentanil or nicomorphin. GA was initiated EVAR was performed as previously described.4with etomidate, fentanyl and pancuronium, and main- No patient required conversion. The same admissiontained with isoflurane and fentanyl as required or a reintervention rate was 7.7%. An endovascular leakcontinuous infusion of sufentanil. In case of hyper- was detected in five patients and was treated with atension and during stent-graft deployment, boluses or repositioning of the prosthesis (three patients) or aa continuous infusion of nitroglycerine were initially percutaneous angioplasty (two patients). A pseudo-administered, supplemented by boluses or a con- aneurysm at the site of prosthesis insertion requiredtinuous infusion of low dose phentolamine when a revision (under LA) in two patients. Wound infectionneeded. Heparin was given prior to arterial incision. occurred in two patients, and ileus in two patients.LA was favoured when the access artery was the Graft occlusion or dislocation and peripheral embolifemoral artery, and an EDA or GA when it was the did not occur.iliac artery. General anaesthesia was used in 20 patients
under the following circumstances: surgical learning
curve (seven patients), anaesthetic conversion (six
patients), iliac access and contraindication to EDA (six Postoperative management
patients) and medical indication (one patient with
undertreated epilepsy). Conversion of LA to GA (five Postoperative analgesic treatment consisted mainly
of anti-inflammatory non-steroidal analgesic and/orpatients) or EDA to GA (one patient) was necessary
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Table 2. Operative haemodynamic data.
LA (63) EDA (8) GA (20) Total (91)
MAP mmHg 90 (±2.2)†, § 82 (±8) 78 (±2.8) 85 (±2)
HR <50/min 10 (15.9%) 1 (12.5%) 7 (35%) 18 (19.7%)
HR >100/min 1 0 0 1 (1%)
CVP mmHg 4.5 (±0.8) 5.0 (±1.5) 5.5 (±1.8) 5.0 (±0.7)
CVP mmHg 3 (±0.6) 4 (±1.3) 5 (±1.9) 4 (±0.7)
Fluid balance ml +1000 (±147)∗, § +1460 (±446) +1950 (±590) +1245 (±202)
Lactate M/l 1.7 (±0.7) 1.8 (±0.5) 1.6 (±1) 1.7 (±0.6)
O2Sat % 95.5 (±0.8) 93 (±2.4) 95.5 (±4) 95 (±0.8)
Vasodilators requirement 44 (69%) 5 (63%) 14 (70%) 63 (69%)
Vasopressors requirement 10 (16%)‡,∗, § 6 (75%) 12 (60%) 28 (31%)
>1 bolus vasopressors 5 (8%) 2 (25%) 10 (50%) 17 (19%)
Values are expressed as number of patients (%) or median±2SE (95% confidence interval). The conversions from EDA or LA to GA are
included in the GA group. MAP: mean arterial pressure; HR: heart rate; CVP: central venous pressure; O2Sat: oxygen saturation.
† LA versus GA and EDA: p<0.0004.
∗ LA versus GA and EDA: p<0.0001.
†† LA versus EDA: p<0.001.
§ LA versus GA: p<0.0001.
intravenous boli of nicomorphin. Patients in the ICU comparison to EDA and p<0.0002 in comparison to
GA). This remained true when we excluded from thewere transferred to the regular ward as far as they
satisfied the usual criteria of cardio-respiratory sta- GA group the three patients who became hypo-
volaemic (p<0.001). Three patients had a significantbility without the need of vasoactive intravenous drugs
or ventilatory support, and as far as they didn’t show CVP variation of 11 (two patients) and 18 (one patient)
mmHg; all three were in the GA group and had eitherany bleeding, infectious or surgical complications.
Patients in the recovery room were transferred by the a haemorrhagic complication (two patients) or a graft
misplacement (one patient).end of the day to the regular ward, following the same
transfer criteria as from the ICU, and were free to Median fluid balance was significantly lower in the
LA (1000±147 ml) or EDA group (1460±446 ml) thandrink clear fluids. Regular diet as well as free am-
bulating were resumed on the first postoperative day. in the GA group (1950±590 ml) (p<0.0001, LA vs
GA). If we exclude the two patients who necessitated
intensive volume resuscitation for haemorrhagic com-
plications, the median fluid balance in the GA group
Statistical evaluation was still significantly higher than in the other groups
(p<0.0001). There was no significant intraoperative
Data values are expressed as median ±2 s.e. (95% variation of arterial lactate level, with a median max-
confidence intervals). Operative and postoperative imal concentration of 1.7±0.6 M/l. Six patients had
variables were compared using Kruskall–Wallis and an arterial lactate concentration higher than 3 M/l:
Chi Square test. Between group differences were evalu- three suffered a haemorrhage complication (lactate
ated by Mann–Whitney U-test with Bonferroni cor- values: 6.4; 5.03; 3.15 M/l); three others had a pre-
rection (p-value multiplied by 3). p<0.05 was existent lactate elevation secondary to tissue ischaemia
considered significant. due to a ruptured abdominal aortic aneurysm (lactate
values: 12.7; 3.5; 3.3 M/l).
There was one transient oxygen desaturation to 78%
after a bolus of sufentanil attributed to a refractory
Results airway closure14 and necessitating an emergency in-
tubation; the O2Sat was otherwise stable and greater
Haemodynamics than 93% in each group with a median minimum
O2Sat of 95±0.8%.
All patients were haemodynamically stable (Table 2). A Eleven patients required blood product transfusion
few patients became hypovolaemic because of surgical (Table 3); four patients (4.4 %) had multiple trans-
blood loss. Three belonged to the GA group after fusions, one in the LA group with a ruptured AAA and
anaesthetic conversion. The patients undergoing LA three in the GA group suffering from a haemorrhagic
complication.required significantly less vasopressors (p<0.0006 in
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Table 3. Blood products requirements.
LA (63) EDA (8) GA (20) Total (91)
Preop. Hb (g/dl) 12 (±0.8) 12.3 (±1.6) 13.5 (±0.9) 13.1 (±0.6)
Postop Hb(g/dl) 10.8 (±0.75) 11.2 (±1.4) 10.8 (±1.3) 10.8 (±0.6)
Nb requiring RBPC 3 (max 5 U) (5%) 0 4 (max 10 U) (20%) 7 (max 10 U) (8%)
Nb requiring FFP 2 (max 4 U) (3%) 0 4 (max 12 U) (20%) 6 (max 12 U) (7%)
Nb requiring Ptls 0 0 2 (12 U) (5%) 2 (12 U) (2%)
Values are expressed as number of patients (%) or median±2SE (95% confidence interval). The conversions from EDA or LA to GA are
included in the GA group. Nb: number of patients; Hb: haemoglobin; RBPS: red blood packed cells; FFP: fresh frozen plasma; Ptls:
platelets. No significant differences between groups.
Table 4. Operating times.
LA (63) EDA (8) GA (20) Total (91)
Operating time (min) 100 (±15)‡∗ 125 (±23) 172.5 (±48) 115 (±17)
Peripheral clamping time (min) 20 (±3)†, ∗ 24.5 (±4) 40 (±11) 22 (±4)
Values are expressed as number of patients (%) or median±2SE (95% confidence intervals). The conversions from EDA or LA to GA are
included in the GA group.
∗ LA versus EDA and GA: p<0.0001.
‡ LA versus GA: p<0.0001.
† LA versus GA: p=0.0003.
Surgery patient to a renal infarct secondary to obstruction of
the left renal artery; one patient had not any obvious
The median duration of surgery (excluding the time aetiology for this increase besides a possible subclinical
hypovolaemia after use of contrast agent.necessary for anaesthesia and patient installation) was
115±17 min with a significantly shorter time in the Thirteen patients developed a leucocytosis but the
median postoperative leucocytes count was not sig-LA group (p<0.0001) (Table 4). The median clamping
time of the femoral or iliac artery was 22±3.5 min. nificantly different from preoperative in each group.
The C-reactive protein (CRP) significantly increased
postoperatively from a median value of 8±13.4 to
95.5±17.8. The median temperature before and after
Morbidity and complications surgery was stable except in one patient who had a
transient postoperative temperature over 40 °C with-There was no intraoperative or 30 days postoperative out any other symptoms for a systemic inflammatorymortality. Two patients (2.2%) died more than 3 months response syndrome (SIRS). There were two localafter surgery for reasons unrelated to the operation. wound infections.There were no perioperative cardiopulmonary or
neurological complications. No patient suffered from
chest pain or showed ECG ischaemic changes. There
was no significant postoperative creatine phos-
phokinase (CK) or creatine phosphokinase isoenzyme Length of stay
(CKMB) elevation. There was no respiratory failure
requiring reintubation or prolonged mechanical vent- Thirty-five patients were referred to ICU for the im-
mediate postoperative course (Table 5): they wereilation and no postoperative pulmonary infection.
There was no postoperative renal dysfunction re- considered at increased risk due to multiple com-
orbidities (18 patients), to intraoperative haemo-quiring a transient or chronic haemodialysis, despite
the use of contrast medium. If we exclude the dynamic instability (four patients) or following surgery
of symptomatic (eight patients) or ruptured AAA (fivetwo patients who were preoperatively dialysed, the
median preoperative creatinine concentration was patients). The median ICU stay was 1 day. Two patients
in the GA group had a delayed extubation because of101±7.8 M/l and postoperatively 100±9.6 M/l.
Three patients had a significant (>50%) but transient haemodynamic instability. The median hospital length
of stay was 5 days. The five patients with rupturedincrease of creatinine concentration that could be at-
tributed in one patient to perioperative haemodynamic AAA had a median ICU length of stay of 1.5 days and
a hospital length of stay of 8 days.instability secondary to haemorrhage, and in one
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Table 5. Length of intensive care unit and hospital stay.
LA (63) EDA (8) GA (20) Total (91)
ICU 17 (27%)‡, ∗ 4 (50%) 14 (70%) 35 (39%)
ICU stay (days) 1 (0.5–2) 1 (1–4) 2 (1–4) 1 (0.5–4)
Hospital stay (days) 3 (3–16)§, † 4.5 (4–12) 5.5 (4–16) 5 (3–16)
Values are expressed as number of patients (%) or median (range). The conversions from EDA or LA to GA are
included in the GA group. ICU: Intensive Care Unit.
∗ LA versus GA and EDA: p=0.0017.
‡ LA versus GA: p<0.0001.
† LA versus GA and EDA: p<0.0002.
§ LA versus GA: p<0.0005.
Discussion vasopressor administration) and less fluid infusion.
Moreover, three-quarters of these patients did not
The major finding of the study is that LA is a safe transit through an ICU bed, and one-quarter utilised
an ICU bed for an even shorter time than all thetechnique for EVAR in most patients. When applicable,
LA provides advantages over EDA or GA because of patients in the other groups.
its simplicity, the haemodynamic stability it provides,
the reduced requirement for intravascular fluid and
the subsequent reduced monitoring and consumption
Conclusionof ICU and hospital beds. The main limitations of
our comparison are the non-randomised nature of
Based on our experience in 91 consecutive patients,allocation of patients in the various anaesthetic groups
we consider LA with liberal sedation the anaestheticand the great disparity in the size of each group. As
of choice for transfemoral, and EDA for transiliacalwe started with this new surgical procedure, the first
EVAR. GA should be restricted to patients with contra-seven patients received a GA. After we were convinced
indications to EDA necessitating a transiliacal access.24that acceptable operative times could be respected
and surgical complications would remain unlikely, we
switched to an almost exclusive LA approach.
A great proportion of patients with aortic aneurysm
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